Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Celldex Therapeutics, Inc. | 233,500 | reported | 08 Jun 2016 | tx 6+51,800 |
| PULSE BIOSCIENCES, INC. | 30,000 | reported | 15 Aug 2025 | tx 10+270,911 |
| Corvus Pharmaceuticals, Inc. | 30,000 | reported | 08 Apr 2025 | tx 1+30,000 |
| STRATEGIC DIAGNOSTICS INC/DE/ | 28,230 | reported | 23 Jun 2015 | tx 20+129,151−209,900 |
| RESPONSE GENETICS INC | 27,000 | reported | 10 Jul 2014 | tx 7+208,500 |
| PHARMACYCLICS INC | 0 | reported | 26 May 2015 | tx 65+100,522−246,423 |
| PhaseBio Pharmaceuticals Inc | 0 | reported | 19 May 2023 | tx 9+102,750−3,750 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Aug 2025 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 30,000 | 0.00 USD | deriv |
| 08 Apr 2025 | GRANT_AWARD | Corvus Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 11,649 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 20,000 | 0.00 USD | deriv |
| 25 May 2023 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 20,000 | 0.00 USD | deriv |
| 25 May 2023 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 28,487 | 0.00 USD | deriv |
| 19 May 2023 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 3,750 | — | |
| 19 May 2023 | EXERCISE | PhaseBio Pharmaceuticals Inc | 3,750 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 20,000 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 79,206 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 3,750 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 17,500 | 0.00 USD | deriv |
| 03 Jun 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 14,000 | 0.00 USD | deriv |
| 20 May 2021 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 20,000 | 0.00 USD | deriv |
| 20 May 2021 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 9,069 | 0.00 USD | deriv |
| 06 Aug 2020 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 32,500 | 0.00 USD | deriv |
| 03 Jun 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 16,000 | 0.00 USD | deriv |
| 09 May 2019 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 2,750 | 0.00 USD | deriv |
| 27 Feb 2019 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 23,000 | 0.00 USD | deriv |
| 27 Feb 2019 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 22,000 | 0.00 USD | deriv |
| 08 Jun 2016 | GRANT_AWARD | Celldex Therapeutics, Inc. | 10,000 | — | |
| 08 Jun 2016 | GRANT_AWARD | Celldex Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 23 Jun 2015 | GRANT_AWARD | STRATEGIC DIAGNOSTICS INC/DE/ | 2,500 | — | |
| 22 Nov 2013 | GRANT_AWARD | STRATEGIC DIAGNOSTICS INC/DE/ | 25,000 | — | deriv |
| 23 Jun 2015 | GRANT_AWARD | STRATEGIC DIAGNOSTICS INC/DE/ | 10,000 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 02 Feb 2012.